Arcutis Biotherapeutics, Inc.

This study tested a cream called ARQ-151 to see if it safely reduces eczema symptoms in young children. Over 650 kids aged 2 to 5 with moderate to severe eczema applied the cream or a placebo once daily for 4 weeks. Doctors measured how much the children's skin cleared up and imp…

This study followed over 1,200 children (ages 2+) and adults with mild to moderate eczema for up to a year to check the long-term safety of a daily-use cream called roflumilast. Participants had already used the cream in earlier short-term studies. The main goal was to track any …

This study tested the safety of a daily cream called roflumilast for treating eczema in infants. It involved 101 babies aged 3 months to under 2 years who used the cream for 4 weeks. The main goal was to check for any side effects or skin reactions from the treatment.